What podcasts say about Lauren Knighty

Every statement, with the speaker, the exact quote and the moment it was said.

What Lauren Knighty has said on podcasts

5 statements · 5 positive

on Multinational pharma-China biotech dealsPositiveOct 6, 2026· BioCentury This Week
Multinational pharma deals with China-based biotechs have increased substantially.
“There's just a huge increase.”
Listen at 4:19
Open the episode · Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winners
on China biotech dealsPositiveOct 6, 2026· BioCentury This Week
China biotech deals are nine higher year-to-date than last year.
“I think we have nine more deals already this year to date than we had last year.”
Listen at 4:21
Open the episode · Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winners
on Recent China biotech dealsPositiveOct 6, 2026· BioCentury This Week
Recent China biotech deals had upfronts above $300 million and values above $2 billion.
“These were relatively big deals. They all had upfront payments of over $300 million or more with total deal values over $2 billion.”
Listen at 4:46
Open the episode · Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winners
on One recent China biotech dealPositiveOct 6, 2026· BioCentury This Week
One recent China biotech deal exceeded $7 billion in total value.
“One of them was over $7 billion.”
Listen at 4:58
Open the episode · Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winners
on RNA-encoded T-cell engagersPositiveOct 6, 2026· BioCentury This Week
RNA-encoded T-cell engagers represent a new therapy class.
“This is kind of a new class of therapies there.”
Listen at 9:09
Open the episode · Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winners

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.